Deng, Yanhong
Shi, Shengying
Feng, Senling
Tan, Xiangping
Wang, Yinling
Yin, Jinjin
Liu, Shaozhi
Gao, Yuanmei
Article History
Received: 20 February 2025
Accepted: 10 July 2025
First Online: 7 August 2025
Declarations
:
: This study analyzed secondary data from the FDA Adverse Event Reporting System (FAERS), a publicly accessible and de-identified database. According to U.S. federal regulations (45 CFR 46.104(d)(4)), research involving publicly available, non-identifiable data does not require Institutional Review Board (IRB) approval or individual informed consent. Therefore, no additional ethics approval or participant consent was required for this study.
: Not applicable.
: The authors declare no competing interests.